We are live on ! Find out more
NUVB.WS

Nuvation Bio Inc Warrants
NUVB.WS

Delisted

NUVB.WS was delisted on the 10th of February, 2026.

Back to rankings

0 hedge funds and large institutions have $0 invested in Nuvation Bio Inc Warrants in 2026 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 21 → 0 (-21)

100% less capital invested

Capital invested by funds: $9.85M → $0 (-$9.85M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 21

Holders
–
Holders Change
-21
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
21
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
EC
EcoR1 Capital
California
-$8.63M
2
DC
Decheng Capital
California
-$213K
3
NCM
Nantahala Capital Management
Connecticut
-$207K
4
GCM
Greenland Capital Management
New York
-$115K
5
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$88K
Name Holding Trade Value Shares
Change 		Change in
Stake
EC
1
EcoR1 Capital
California
– -$8.63M -963,333 Closed
DC
2
Decheng Capital
California
– -$213K -646,057 Closed
NCM
3
Nantahala Capital Management
Connecticut
– -$207K -626,191 Closed
GCM
4
Greenland Capital Management
New York
– -$115K -348,960 Closed
Adage Capital Partners
5
Adage Capital Partners
Massachusetts
– -$88K -266,666 Closed
BCM
6
Boxer Capital Management
California
– -$88K -266,666 Closed
Franklin Resources
7
Franklin Resources
California
– -$88K -266,666 Closed
DM
8
Deerfield Management
New York
– -$55K -166,666 Closed
LCM
9
Laurion Capital Management
New York
– -$55K -166,579 Closed
BlackRock
10
BlackRock
New York
– -$50.7K -153,756 Closed
RSCM
11
Rock Springs Capital Management
Maryland
– -$44.2K -134,028 Closed
SB
12
Samsara BioCapital
California
– -$41K -124,119 Closed
WAM
13
Wolverine Asset Management
Illinois
– -$40.6K -122,921 Closed
DCM
14
DME Capital Management
New York
– -$33K -100,000 Closed
ACP
15
Acuta Capital Partners
California
– -$30K -90,832 Closed
Citadel Advisors
16
Citadel Advisors
Florida
– -$24.3K -73,686 Closed
LGM
17
Logos Global Management
California
– -$22K -66,666 Closed
IP
18
Intellectus Partners
California
– -$10.7K -32,298 Closed
Victory Capital Management
19
Victory Capital Management
Texas
– -$6.73K -20,381 Closed
HPCM
20
Hunter Perkins Capital Management
Illinois
– -$7K -20,000 Closed
Barclays
21
Barclays
United Kingdom
– -$541 -1,638 Closed

NUVB.WS Hedge Fund Activity: Q1 2026 in Review

0 of the 8,161 institutional investors tracked by Wall St. Rank reported a position in Nuvation Bio Inc Warrants (NUVB.WS) for Q1 2026, worth a combined $0 — down 100% from $9.85M a quarter earlier.

Sellers outnumbered buyers: 21 funds closed out of NUVB.WS and 0 opened new positions — a net loss of 21 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was EcoR1 Capital, exiting entirely with an estimated $8.63M sold.

  • 0 institutional investors held Nuvation Bio Inc Warrants (NUVB.WS) as of Q1 2026, down from 21 in Q4 2025.
  • Funds reported $0 of Nuvation Bio Inc Warrants stock for Q1 2026, down 100% quarter-over-quarter.
  • 0 funds opened new Nuvation Bio Inc Warrants positions in Q1 2026 and 21 closed out, a net change of -21 holders.
  • The largest Nuvation Bio Inc Warrants seller in Q1 2026 was EcoR1 Capital, an estimated $8.63M sold.

Based on aggregated 13F filings for Q1 2026.